Jan Hillson
Equibles does not estimate personal net worth.
About Jan Hillson
Climb Bio, Inc. reported in an 8-K filed June 27, 2024 that Jan Hillson was appointed Senior Clinical Advisor. Climb Bio, Inc. reported in an 8-K filed June 27, 2024 that Jan Hillson was appointed Senior Clinical Advisor, effective June 27, 2024. Climb Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Climb Bio, Inc. includes Aoife Brennan (CEO, CFO and Board Member), Aoife Brennan, M.B., Ch.B. (CEO and Board Member), Dr. Stephen Thomas (CEO) and 7 others.
“Eliem is announcing additions to its executive leadership team with the appointment of Aoife Brennan, M.B., Ch.B., as President and Chief Executive Officer and Jan Hillson, M.D., as Senior Clinical Advisor.”
“Announces the appointments of Dr. Aoife Brennan as President, Chief Executive Officer and Director, and Dr. Jan Hillson as Senior Clinical Advisor; Dr. Stephen Thomas, former Tenet CEO, appointed to Eliem's Board of Directors”
Affiliation history
-
Climb Bio, Inc. (CLYM)
SEC 8-K
Current2024-06-27–present
Company network
Leadership on record at Climb Bio, Inc.
- Aoife Brennan CEO, CFO, Board Member
- Aoife Brennan, M.B., Ch.B. CEO, Board Member
- Dr. Stephen Thomas CEO
- Stephen Thomas CEO, Board Member
- Andrew Levin Chairman, CFO
- Brett Kaplan CFO, COO
- Cindy Driscoll CFO
- Susan Altschuller CFO, Chief Accounting Officer
- Susan Altschuller, Ph.D., MBA CFO
- Brett Kaplan, M.D. COO